Award
Delivery Order #SPE2DR26FP1YB
Delivery Order for Rivastigmine Capsules Under AmerisourceBergen Pharmaceutical Contract
Buyer
Defense Logistics Agency
Award Amount
$356.34
Ceiling
$356.34
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 17, 2026
Identifier
SPE2DR26FP1YB
NAICS
424210
This delivery order contract represents a specific procurement action awarded to AmerisourceBergen Drug Corp, a prominent pharmaceutical sourcing and distribution company. The product acquired is a supply of Rivastigmine 3 mg capsules, intended to support health services with essential medication. This delivery order is part of a broader, substantial indefinite delivery/indefinite quantity (IDV) contract awarded to AmerisourceBergen, aimed at enhancing the pharmaceutical supply chain efficiency for public sector healthcare. The scope of this delivery includes the delivery of the specified medication within a short, defined timeframe, ensuring timely availability of this pharmaceutical product. This award follows a competitive acquisition process under the umbrella of the larger IDV contract. The contract period for this delivery order is a brief, focused interval, reflecting the need for a prompt fulfillment of medical supplies. The parent award contract, which governs this delivery order, is a multi-year agreement aligning with the agency’s goal to maintain a reliable pharmaceutical supply network.
Description
4570837035!RIVASTIGMINE 3 MG CAPSULE 60S